Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
帕博利珠单抗联合利妥昔单抗治疗复发或难治性滤泡性淋巴瘤的安全性和疗效
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021006240
Nastoupil, Loretta J; Chin, Collin K; Westin, Jason R; Fowler, Nathan H; Samaniego, Felipe; Cheng, Xiaoyun; Ma, Man Chun John; Wang, Zhiqiang; Chu, Fuliang; Dsouza, Ly; Obi, Chizobam; Mims, Jennifer; Feng, Lei; Zhou, Shouhao; Green, Michael; Davis, Richard Eric; Neelapu, Sattva S